Novel Types of Frontotemporal Lobar Degeneration: Beyond Tau and TDP-43
- 21 May 2011
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 45 (3) , 402-408
Abstract
Most cases of frontotemporal lobar degeneration (FTLD) are characterized by the abnormal accumulation of either the microtubule-associated protein tau or the transactive response DNA-binding protein with Mr 43 kDa, TDP-43 (FTLD-tau and FTLD-TDP, respectively). However, there remain ∼10% of cases, composed of a heterogenous collection of uncommon disorders, for which the molecular basis remains uncertain. In this review, we describe the characteristic genetic, clinical, and pathological features of the major tau/TDP-negative FTLD subtypes, with focus on recent advances in our understanding of their molecular basis. This includes the discovery that the pathological changes in atypical FTLD with ubiquitinated inclusions, neuronal intermediate filament inclusion disease, and basophilic inclusion body disease are immunoreactive for the fused in sarcoma (FUS) protein, resulting in the creation of a new molecular subgroup (FTLD-FUS), and studies clarifying the functional consequences of pathogenic CHMP2B mutations.Keywords
This publication has 64 references indexed in Scilit:
- FUS Immunogold Labeling TEM Analysis of the Neuronal Cytoplasmic Inclusions of Neuronal Intermediate Filament Inclusion Disease: A Frontotemporal Lobar Degeneration with FUS ProteinopathyJournal of Molecular Neuroscience, 2011
- The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion diseaseActa Neuropathologica, 2010
- FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degenerationActa Neuropathologica, 2010
- Fus gene mutations in familial and sporadic amyotrophic lateral sclerosisMuscle & Nerve, 2010
- Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degenerationJournal of Neurology, 2009
- Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an updateActa Neuropathologica, 2009
- Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion diseaseActa Neuropathologica, 2009
- Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementiaProceedings of the National Academy of Sciences, 2009
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendationsActa Neuropathologica, 2008
- Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative diseaseJournal of Cell Biology, 2007